| Financial Year |
March 31 2023 |
| Monetary Funds |
550,281,919.26 |
| Held-for-trading Financial Assets |
38,071,684.72 |
| Notes Receivable |
7,034,754.40 |
| Accounts Receivable |
790,806,501.35 |
| Advances to Suppliers |
14,410,912.92 |
| Other Receivables |
11,418,449.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
261,297,816.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,437,229.21 |
| Total Current Assets |
1,812,618,134.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,999,220.68 |
| Investment Properties |
6,098,272.45 |
| Fixed Assetes |
369,564,759.61 |
| Under-construction Projects |
161,177,908.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
40,542,380.16 |
| R&D expenses |
-- |
| Goodwill |
113,120,771.15 |
| Long-Term Deferred and Prepaid Expenses |
12,829,111.71 |
| Deferred Income Tax Assets |
30,410,466.69 |
| Other Non-Current Assets |
27,820,982.12 |
| Sub-Total of Non-Current Assets |
866,949,712.88 |
| Total Assets |
2,679,567,847.20 |
| Short-Term Loans |
168,260,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
200,278,070.65 |
| Accounts Payable |
163,734,514.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,026,893.37 |
| Taxes Payable |
3,261,712.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
103,722,439.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,861,572.73 |
| Other Current Liabilities |
147,669,157.97 |
| Sub-Total of Current Liabilities |
850,839,215.28 |
| Long-term Loans |
123,365,395.08 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,030,313.46 |
| Deferred Income Tax Liabilities |
9,076,415.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
230,308,084.50 |
| Total Liabilities |
1,081,147,299.78 |
| Paid-In Capital(Or Share Stock) |
156,000,000.00 |
| Capital Surplus |
988,336,193.40 |
| Surplus Reserve |
50,293,480.47 |
| LESS:Treasury Stock |
633,849.00 |
| Undistributed Profits |
380,229,930.42 |
| Minority Stockholder's Interest |
24,573,117.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,573,847,430.10 |
| Owner's Equity（Stockholder's Equity） |
1,598,420,547.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,679,567,847.20 |
